When Should I Start Broad-spectrum Antibiotics?

Overview

Journal Intensive Care Med

Specialty Critical Care

Date 2024 Sep 23

PMID 39311904

Authors

Jean-Francois Timsit

Pieter Depuydt

Souha S Kanj

Affiliations

Soon will be listed here.

References

Rhee C, Kadri S, Dekker J, Danner R, Chen H, Fram D . Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use. JAMA Netw Open. 2020; 3(4):e202899. PMC: 7163409. DOI: 10.1001/jamanetworkopen.2020.2899. View

Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith C, French C . Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021; 47(11):1181-1247. PMC: 8486643. DOI: 10.1007/s00134-021-06506-y. View

Mancuso G, Midiri A, Gerace E, Biondo C . Bacterial Antibiotic Resistance: The Most Critical Pathogens. Pathogens. 2021; 10(10). PMC: 8541462. DOI: 10.3390/pathogens10101310. View

Wiens J, Snyder G, Finlayson S, Mahoney M, Celi L . Potential Adverse Effects of Broad-Spectrum Antimicrobial Exposure in the Intensive Care Unit. Open Forum Infect Dis. 2018; 5(2):ofx270. PMC: 5804637. DOI: 10.1093/ofid/ofx270. View

Zakhour J, Haddad S, Kerbage A, Wertheim H, Tattevin P, Voss A . Diagnostic stewardship in infectious diseases: a continuum of antimicrobial stewardship in the fight against antimicrobial resistance. Int J Antimicrob Agents. 2023; 62(1):106816. DOI: 10.1016/j.ijantimicag.2023.106816. View

Kadri S, Lai Y, Warner S, Strich J, Babiker A, Ricotta E . Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. Lancet Infect Dis. 2020; 21(2):241-251. PMC: 7855478. DOI: 10.1016/S1473-3099(20)30477-1. View

Torres A, Niederman M, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H . International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the.... Eur Respir J. 2017; 50(3). DOI: 10.1183/13993003.00582-2017. View

Harris P, Tambyah P, Lye D, Mo Y, Lee T, Yilmaz M . Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial. JAMA. 2018; 320(10):984-994. PMC: 6143100. DOI: 10.1001/jama.2018.12163. View

Finazzi S, Luci G, Olivieri C, Langer M, Mandelli G, Corona A . Tissue Penetration of Antimicrobials in Intensive Care Unit Patients: A Systematic Review-Part I. Antibiotics (Basel). 2022; 11(9). PMC: 9495190. DOI: 10.3390/antibiotics11091164. View

10.

Webb B, Sorensen J, Jephson A, Mecham I, Dean N . Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: a cohort study. Eur Respir J. 2019; 54(1). DOI: 10.1183/13993003.00057-2019. View

11.

Timsit J, Bassetti M, Cremer O, Daikos G, De Waele J, Kallil A . Rationalizing antimicrobial therapy in the ICU: a narrative review. Intensive Care Med. 2019; 45(2):172-189. DOI: 10.1007/s00134-019-05520-5. View

12.

Dessajan J, Timsit J . Impact of Multiplex PCR in the Therapeutic Management of Severe Bacterial Pneumonia. Antibiotics (Basel). 2024; 13(1). PMC: 10812737. DOI: 10.3390/antibiotics13010095. View